Latest news
Lucid Diagnostics Secures Commercial Coverage Policy for Its Esophageal DNA Test - Clinical Lab ProductsClinical Lab Products · Fri, 07 Aug 2026 12:20:13 GMTLucid's EsoGuard Is the Only Esophageal Precancer Test Meeting Coverage Criteria - Stock TitanStock Titan · Wed, 05 Aug 2026 12:46:00 GMTLucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:36:00 GMTLumos Diagnostics (ASX:LDX) Secures US$767,800 FebriDx® Order from PHASE Scientific - KalkineKalkine · Tue, 04 Aug 2026 01:12:00 GMTLumos Diagnostics secures US$768,000 FebriDx order as US commercial rollout gathers pace - Proactive financial newsProactive financial news · Tue, 04 Aug 2026 00:55:14 GMTEpitel Secures $26 Million Series B to Expand Remote Wireless EEG Monitoring - Business WireBusiness Wire · Tue, 28 Jul 2026 10:00:00 GMT